U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Approvals and Databases
  5. Quarterly Inactive Ingredient Database (IID) Change Log
  1. Drug Approvals and Databases

Quarterly Inactive Ingredient Database (IID) Change Log

Understanding the Change Log

Welcome to the new Quarterly IID Change Log. FDA publishes the IID on a quarterly basis. The Quarterly IID Change Log displays changes made since the previous quarterly IID publication.

The Quarterly IID Change Log is divided into two parts showing two types of changes: quarterly corrected records and quarterly deleted records. Note that new records are displayed on the primary IID webpage, not in the Quarterly IID Change Log. New records include the first appearance of an excipient in the IID, higher potencies for excipients, new routes of administration and dosage forms.  New records are identified in the IID with a “Y” in Updated Record column.

What is displayed as quarterly corrected records?

The list of corrected records displays the current “changed” record above the previous record as it appeared in the last quarterly IID publication. The type of change made is evident in this display format which gives a before and after view of each changed record.  Corrected records are those for which the ingredient name, unit of measure or potency were corrected in the current quarterly IID publication. Note that potency corrections that resulted in a decreased potency value are displayed in the Change Log because these are corrections of erroneous data. Increases in potency are displayed on the IID primary webpage and are designated as new entries.

What is displayed as quarterly deleted records?

The list of deleted records displays records that appeared in the previous IID publication but have been deleted from the current publication. Excipients are seldom completely removed from the IID. Most “deletions” reflect corrections of the route of administration or dosage form associated with the excipient record. These types of corrections create a new record for the excipient, thus deleting the old record.  For example, the record for BETADEX SULFOBUTYL ETHER SODIUM, route of administration INTRAVENOUS, dosage form POWDER with maximum potency 270.00 mg/ml appeared on the deleted records list in October 2019. The reason for deletion of this record was a correction of the dosage form from POWDER to INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. The new record for this excipient appeared in the October 2019 IID with the correct dosage form. Along with the correction of dosage form, the units of measure were also update for this record to percentage weight per volume (27 %w/v).

Go to Most Recent Changes to the IID Database